• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Why International Expansion Must Remain a Priority for Cerner, Epic, Allscripts, MEDITECH

Share:

August 26, 2020

Highlights on this story:
  • How the top US acute EHR vendors, namely Cerner, Epic, Allscripts, and MEDITECH (+85% share of US acute market in terms of revenues), have progressed on international expansion.

As highlighted below, there is a significant variance amongst the big four in terms of revenue and share of business outside the US. Cerner has by far the highest revenue at more than $650M in 2019, representing 12% of its business. Whilst MEDITECH has considerably lower revenue than Cerner, its international revenue is broadly similar to a share of its total revenue.

By contrast, Allscripts and MEDITECH each has international business that is comparable in terms of revenues, but as a share of overall revenues, international is much less important for Allscripts.

Allscripts’ international revenue was lower than Epic, Cerner, and Meditech in 2018, however, its growth in 2019 enabled it to overtake MEDITECH and become the third largest of the four vendors in 2019.

Read more here

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • FDA releases final rule on classification, reclassification of medical devicesFDA releases final rule on classification, reclassification of medical devices
  • Pharma and healthcare companies braced for Trump shake-upPharma and healthcare companies braced for Trump shake-up
  • Smith Technologies Completes Acquisition by Francisco Partners and Rebrands as RedSail TechnologiesSmith Technologies Completes Acquisition by Francisco Partners and Rebrands as RedSail Technologies
  • BioIQ Releases At-home COVID-19 and Flu Saliva Sample Collection KitBioIQ Releases At-home COVID-19 and Flu Saliva Sample Collection Kit
  • Report: AstraZeneca Eyes Gilead Sciences for Potential MergerReport: AstraZeneca Eyes Gilead Sciences for Potential Merger
  • Pharma E-Commerce Market Statistics 2021Pharma E-Commerce Market Statistics 2021
  • 4 Digital Health Tools for Combating Opioid Addiction in 2020 and Beyond4 Digital Health Tools for Combating Opioid Addiction in 2020 and Beyond
  • Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in CashLigand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications